
Thermo Fisher Scientific
NEWS
The diagnostic tool will use Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test to identify HER2 (human epidermal growth factor receptor 2) gene mutations.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 18, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 7, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
For this year, 2020, it plans to invest more than $475 million in new capabilities and capacity.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
No financial terms were disclosed.
Qiagen manufactures diagnostic tests for a variety of diseases including cancer and, currently, the coronavirus that causes COVID-19.
JOBS
IN THE PRESS